ArticlePloS one2026
Herbal medicine use and renal dysfunction among persons living with HIV on Tenofovir-based ART in Kampala, Uganda.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHIV/AIDS remains a major public health issue, with about 1.4 million people infected in Uganda by 2020. In rural western Uganda, 57.6% of people living with HIV (PLWH) use herbal medicine (HM) alongside antiretroviral therapy (ART). Combining HM with a tenofovir disoproxil fumarate (TDF)-based ART regimen may increase risks of renal dysfunction, death, and treatment costs, highlighting the need to study their combined effects.
objectiveTo determine the prevalence of herbal medicine use and its association with renal dysfunction among patients on tenofovir antiretroviral treatment-based regimen at ISS clinic Mulago.
methodsA cross-sectional study at MJAP ISS-clinic involved 414 HIV/AIDS patients on TDF-based ART from March-May 2023. Data on herbal medicine use and ART regimen were collected via interviews; blood samples were taken for renal function. Additional clinical and demographic data were extracted from records. All data were entered into Epidata and analyzed using STATA version 17.
resultsWe enrolled 414 participants with median age (interquartile range) of 36 (30,44) years, majority were female 290 (70.1) and were on firstline regimen 392 (94.7). The prevalence of herbal medicine use was 70.8% (95% CI 66.2-74.9). The commonly used herbal medicines reported were concoction/crude, medicated clay and powdered products. The overall renal dysfunction prevalence was 22.5% (95 CI 18.7-26.8) The median serum creatinine levels among herbal medicine users was 96 µmol/litre and 88.8 µmol/litre among non-users. There was a significant difference in the median serum creatinine in the two groups (P = 0.028). There was no significant difference in the urea levels in the two groups (2.99 mmol/litre in herbal medicine users versus 2.84 mmol/litre in non-users, P = 0.689). Herbal medicine use was significantly associated with renal dysfunction (aPR-2.31, 95% CI 1.35-3.97). Other factors that were associated with renal dysfunction were age (aPR-1.54, 95% CI 1.08-2.22) sex (aPR-0.52, 95% CI 0.33-0.83), hypertension (aPR-3.43, 95% CI 2.47-4.76) and diabetes (aPR-1.79, 95% CI 1.39-2.31).
conclusionHealth care workers should screen for herbal medicine use among ART patients and regularly monitor their renal function to detect dysfunction. The Ministry of Health and health care workers should also emphasize educating patients about the potential risks of combining herbal medicine with ART.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.